imgboxbg

News

[Recommend]

IASO Biotherapeutics Raises $60 Million in Series B Financing led by GL Ventures to Advance Cell Therapies for Cancer Care

  • Categories:Press Release
  • Author:
  • Origin:
  • Time of issue:2020-03-23 09:00
  • Views:237
[Recommend]

IASO Biotherapeutics Raises $60 Million in Series B Financing led by GL Ventures to Advance Cell Therapies for Cancer Care

  • Categories:Press Release
  • Author:
  • Origin:
  • Time of issue:2020-03-23 09:00
  • Views:237
Information

 

IASO Biotherapeutics recently announced the completion of $60 million in series B financing led by GL Ventures, which is a venture capital fund of Hillhouse Capital focusing on early-stage innovative companies. Biomedicine and medical devices are its key investment areas. This new funding will mainly go toward expanding the company’s product pipeline, promoting the progress of current projects (including regulatory applications and clinical trials in China and the United States), improving the technology of fully human antibody development platform, expanding cooperation with leading international research and development institutions, and accelerating the construction of commercial facilities.

 

IASO Biotherapeutics